Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Proceedings of the National Academy of Sciences of the United States of America|June 23, 2006
Targeted gene disruption of methionine aminopeptidase 2 results in an embryonic gastrulation defect and endothelial cell growth arrestJing-Ruey J Yeh, Rong Ju, Cathleen M Brdlik, et al.ACS Medicinal Chemistry Letters|December 21, 2019
Evolution of Cereblon-Mediated Protein Degradation as a Therapeutic ModalityPhilip P Chamberlain, Laura A D'Agostino, J Michael Ellis, et al.Nature Structural & Molecular Biology|April 7, 2020
Crystal structure of the SALL4-pomalidomide-cereblon-DDB1 complexMary E Matyskiela, Thomas Clayton, Xinde Zheng, et al.Science (New York, N.Y.)|November 15, 2022
Molecular glue CELMoD compounds are regulators of cereblon conformationEdmond R Watson, Scott Novick, Mary E Matyskiela, et al.ACS Chemical Biology|November 18, 2020
Cereblon Modulators Target ZBTB16 and Its Oncogenic Fusion Partners for Degradation via Distinct Structural DegronsMary E Matyskiela, Jinyi Zhu, Joshua M Baughman, et al.Journal of Medicinal Chemistry|April 21, 2017
A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and AiolosMary E Matyskiela, Weihong Zhang, Hon-Wah Man, et al.Nature Chemical Biology|September 8, 2018
SALL4 mediates teratogenicity as a thalidomide-dependent cereblon substrateMary E Matyskiela, Suzana Couto, Xinde Zheng, et al.Nature|June 25, 2016
A novel cereblon modulator recruits GSPT1 to the CRL4(CRBN) ubiquitin ligaseMary E Matyskiela, Gang Lu, Takumi Ito, et al.Blood Cancer Discovery|May 24, 2021
Avadomide induces degradation of ZMYM2 fusion oncoproteins in hematologic malignanciesAline Renneville, Jessica A Gasser, Daniel E Grinshpun, et al.Pageof 2